Finance

Lists
032300:KOSDAQ
Korea Pharma Co Ltd
â‚©8,480.00
-0.12%
(-10.00) 1D
Oct 20, 3:30:25 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 032300...
Open
â‚©8,450
High
â‚©8,560
Low
â‚©8,210
Mkt. cap
92.49B
Avg. vol.
148.69K
Volume
23.02K
Dividend
0.59%
Quarterly dividend
â‚©12
Ex-dividend date
Dec 27, 2024
52-wk high
â‚©14,950
52-wk low
â‚©6,350
EPS
-â‚©71
Shares outstanding
10.91M
No. of employees
282
Open
â‚©8,450
High
â‚©8,560
Low
â‚©8,210
Mkt. cap
92.49B
Avg. vol.
148.69K
Volume
23.02K
Dividend
0.59%
Quarterly dividend
â‚©12
Ex-dividend date
Dec 27, 2024
52-wk high
â‚©14,950
52-wk low
â‚©6,350
EPS
-â‚©71
Shares outstanding
10.91M
No. of employees
282
News stories
From web sources and news partners
About Korea Pharma Co Ltd
CEOPark Eun-hee
Employees282
Founded1974
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
24.00B
19.43B
24.60B
25.91B
Cost of goods sold
15.28B
13.79B
15.52B
15.71B
Cost of revenue
15.28B
13.79B
15.52B
15.71B
Research and development expenses
497.60M
519.81M
538.89M
373.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.00B
6.82B
6.61B
6.88B
Operating expense
8.21B
7.95B
7.78B
8.03B
Total operating expenses
23.49B
21.74B
23.30B
23.74B
Operating income
507.40M
-2.31B
1.31B
2.16B
Other non operating income
-2.64M
-1.02B
40.48M
309.15M
EBT including unusual items
-155.65M
-4.18B
763.09M
1.61B
EBT excluding unusual items
-238.06M
-4.17B
508.49M
1.84B
Income tax expense
-134.74M
-1.42B
80.61M
285.87M
Effective tax rate
86.57%
33.95%
10.56%
17.76%
Other operating expenses
157.70M
131.92M
149.25M
132.42M
Net income
-20.90M
-2.76B
682.48M
1.32B
Net profit margin
-0.09%
-14.19%
2.77%
5.11%
Earnings per share
-
-
-
-
Interest and investment income
183.53M
228.72M
243.76M
242.89M
Interest expense
-925.10M
-952.60M
-988.26M
-826.18M
Net interest expenses
-741.57M
-723.88M
-744.50M
-583.29M
Depreciation and amortization charges
310.55M
311.79M
309.28M
311.66M
EBITDA
1.29B
-1.53B
2.07B
2.92B
Gain or loss from assets sale
-
-1.22M
-
-
AI content may include mistakes. Learn more
Google apps